Adverse effects of temazepam in older adults with chronic insomnia

Human Psychopharmacology

Volumn 18, Issue 1, 2003, Pages 75-82

  Morin, Charles M ^a   Bastien, Celyne H ^a   Brink, Douglas ^b   Brown, Timothy R ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic insomnia; Older adults; Temazepam

Indexed keywords

BENZODIAZEPINE DERIVATIVE; FLURAZEPAM; HYPNOTIC AGENT; PLACEBO; SEDATIVE AGENT; TEMAZEPAM; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ADULT; AFFECTIVE NEUROSIS; AGED; AGITATION; ANXIETY DISORDER; ARTICLE; ATAXIA; AUTONOMIC DYSFUNCTION; BEHAVIOR DISORDER; BEHAVIOR THERAPY; CHRONIC DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; CONCENTRATION LOSS; CONFUSION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DROWSINESS; DRUG ABSORPTION; DRUG EFFECT; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; DRUG TOLERANCE; DRUG USE; DYSPNEA; EXCITABILITY; FATIGUE; FEMALE; HEADACHE; HUMAN; INSOMNIA; LETHARGY; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MOTOR DYSFUNCTION; MUSCLE WEAKNESS; NAUSEA AND VOMITING; NIGHTMARE; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; SEDATION; SENSORY DYSFUNCTION; SIDE EFFECT; SYNCOPE; TRANQUILIZING ACTIVITY; VERTIGO; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; ANTI-ANXIETY AGENTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; QUESTIONNAIRES; SLEEP INITIATION AND MAINTENANCE DISORDERS; TEMAZEPAM;

EID: 0037275549     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.454     Document Type: Article

References (25)

1. Bixler EO, Kales A, Soldatos CR, Kales JD. 1978. Effectiveness of temazepam with short, intermediate, and long-term use: sleep laboratory evaluation. J Clin Pharmacol 18: 110-118.
2. Bliwise DL. 1993. Sleep in normal aging and dementia. Sleep 16: 40-81.
3. Bootzin RR, Epstein D, Wood JM. 1991. Stimulus control instructions. In Case Studies in Insomnia, Hauri P (ed.). Plenum Press: New York; 19-28.
4. Chilcott LA, Shapiro CM. 1996. The socioeconomic impact of insomnia: an overview. Pharmaco Economics 10(Suppl. 1): 1-14.
5. Fancourt G, Castleden M. 1986. The use of benzodiazepine with particular reference to the elderly. Br J Hosp Med 35: 321-326.
6. Fillingim JM. 1982. Double-blind evaluation of temazepam, flurazepam, and placebo in geriatric insomniacs. Clin Ther 4: 369-380.
7. Ford DE, Kamerow DB. 1989. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? JAMA 262: 1479-1484.
8. Heel RC, Brogden RN, Speight TM, Avery GS. 1981. Temazepam: a review of its pharmacological properties and therapeutic efficacy as a hypnotic. Drugs 21: 321-340.
9. Heffron WA, Roth P. 1979. Double-blind evaluation of the safety and hypnotic efficacy of temazepam in insomniac outpatients. Br J Clin Pharmacol 8: 69S-72S.
10. Lader M. 1983. Insomnia and short-acting benzodiazepine hypnotics. J Clin Psychiatry 21: 321-340.
11. Lichstein KL, Morin CM. 2000. Treatment of Late-Life Insomnia. Sage: Newberry Park, California.
12. Mellinger GD, Balter MB, Uhlenhuth EH. 1985. Insomnia and its treatment: prevalence and correlates. Arch Gen Psychiatry 42: 225-232.
13. Mitler MM, Carsdadon MA, Phillips RL, et al. 1979. Hypnotic efficacy of temazepam: a long-term sleep laboratory evaluation. Br J Clin Pharmacol 8: 63S-68S.
14. Morin CM. 1993. Insomnia. Psychological Assessment and Management. Guilford Press: New York, NY.
15. Morin CM, Colecchi C, Stone J, Sood R, Brink D. 1999a. Behavioral and pharmacological therapies for late-life insomnia. JAMA 281: 991-999.
16. Morin CM, Hauri PJ, Espie CA, Spielman AJ, Buysse DJ, Bootzin RR. 1999b. Nonpharmacologic treatment of chronic insomnia. Sleep 22: 1134-1156.
17. Mullan E, Katona C, Bellew M. 1994. Patterns of sleep disorders and sedative hypnotic use in seniors. Drugs Aging 5: 149-158.
18. National Institute of Health. 1984. Drug and insomnia: the use of medications to promote sleep. JAMA 251: 2410-2414.
19. Pallesen S, Nordhus IH, Kvale G. 1998. Nonpharmacological interventions for insomnia in older adults: a meta-analysis of treatment efficacy. Psychotherapy 35: 472-482.
20. Pollak CP, Perlick D. 1991. Sleep problems and institutionalization of the elderly. J Geriatr Psychiatry Neurol 15: 123-135.
21. Ray WA. 1992. Psychotropic drugs and injuries among the elderly: a review. J Clin Psychopharmacol 12: 386-396.
22. Seidel WF, Cohen SA, Bliwise NG, et al. 1988. Triazolam, temazepam, and placebo for insomnia in the elderly. Sleep Res 17: 141-145.
23. Simon GE, VonKorff M. 1997. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 154: 1417-1423.
24. Spielman AJ, Saskin P, Thorpy MJ. 1987. Treatment of chronic insomnia by restriction of time in bed. Sleep 10: 45-56.
25. Vignola A, Lamoureux C, Bastien CH, Morin CM. 2000. Effects of chronic insomnia and use of benzodiazepines on daytime performance in older adults. J Gerontol (Psychol Sci) 55: 54-62.